# Improving Sleep and AD Biomarkers

> **NCT06029894** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 100 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Citicoline Supplement
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06029894
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-15
- **Primary completion:** 2025-12-21
- **Final completion:** 2025-12-21
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029894, "Improving Sleep and AD Biomarkers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06029894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*